The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting

Jan 1, 1980·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·W CullmannP Jürgens

Relationships between metabolic and hemostatic variables in uncomplicated diabetes

Jul 1, 1981·Acta diabetologica latina·C VerganiP M Mannucci

Hypoglycemic therapy and hemostasis in maturity- onset diabetes mellitus: existence of an early prethrombotic state

Jan 1, 1982·Acta diabetologica latina·G GrignaniE Ferrari

Factor VIII-related antigen levels in normal pregnancy and puerperium

Apr 1, 1985·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S Y ChanA Yam

Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina

Nov 14, 1997·Journal of the American College of Cardiology·S YazdaniL E Rabbani

Coagulation activation and hyperviscosity in infection

Jul 1, 1979·British Journal of Haematology·S G RichardsonJ Stuart

Serial changes in coagulation and viscosity during sickle-cell crisis

Jan 1, 1979·British Journal of Haematology·S G RichardsonR M Wilcox

Factor VIII complex in uraemia and effects of haemodialysis

May 23, 1981·British Medical Journal·J H TurneyM J Weston

Haemostatic function in myocardial infarction

Jan 1, 1986·British Heart Journal·A HamstenL Mettinger

Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients

Jul 1, 1980·Journal of Clinical Pathology·F PusineriM B Donati

Coagulation problems in human pregnancy

May 1, 1979·Postgraduate Medical Journal·C W Redman

Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping

May 1, 1994·The Annals of Thoracic Surgery·M H StaplesR L Berger

Activation of intrinsic coagulation pathway in pre-eclampsia

Jan 1, 1986·The American Journal of Medicine·N D VaziriA Barbari

Aluminium hydroxide adsorption and factor VIII clotting assays

Jul 5, 1980·Lancet·M J Seghatchian, I J Mackie

Factor VIII related antigen and coagulant activity in intrauterine growth retardation

Jan 1, 1979·Thrombosis Research·K A WhighamC R Prentice

The influence of LMW heparin on the coagulation and fibrinolytic response to surgery

Jan 1, 1985·Thrombosis Research·E MelissariV V Kakkar

The use of a macroscopic aggregation test for Von Willebrand factor as an indicator of endothelial damage

Jul 1, 1977·Thrombosis Research·L N HargreavesA S Todd

A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin

May 1, 1982·Thrombosis Research·K L Mettinger

Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma

Jun 1, 1985·European Journal of Cancer & Clinical Oncology·P M MannucciN Cascinelli

Factor VIII related antigen in gestational trophoblastic disease

Oct 1, 1985·British Journal of Obstetrics and Gynaecology·P H ChanH K Ma

Platelet function and coagulation in normal and preeclamptic pregnancy

Sep 1, 1986·Thrombosis Research·F PekonenO Ylikorkala

Immunoquantitation of von Willebrand factor (factor VIII-related antigen) in vinyl chloride exposed workers.

Jan 31, 1992·Cancer Letters·O FromentC Trépo

Nutritional prevention of pre-eclampsia--a special role for 1 series prostaglandin precursors?

Sep 1, 1982·Medical Hypotheses·M F McCarty

Immunoquantitation of factor VIII-related antigen (von Willebrand factor antigen) in prostate cancer.

Jun 30, 1988·Cancer Letters·R J AblinM J Gonder

The destruction of factor VIII clotting activity by thrombin and plasmin

May 1, 1980·Thrombosis Research·K W Denson, C W Redman

Plasma levels of protease inhibitors in acute myeloid leukemia at the onset of the disease and during antiblastic therapy

Jan 1, 1980·Thrombosis Research·G GambaE Ascari

The factor VIII ratio in normal and pathological pregnancies

Oct 1, 1983·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M C ScholtesH L Haak

Predictors for heparin resistance in patients undergoing coronary artery bypass grafting

Dec 10, 1999·Perfusion·M RanucciA Frigiola

Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation

Jan 1, 1990·Stroke; a Journal of Cerebral Circulation·C GustafssonJ Svensson

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

Oct 1, 1984·Cancer·L T GoodnoughO H Pearson

Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis

Nov 8, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·F BiloraA Girolami

Plasma haemostatic factors and diabetic retinopathy

Jun 1, 1983·European Journal of Clinical Investigation·T L DornanR C Turner

Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis

Feb 1, 1980·European Journal of Clinical Investigation·C V ProwseM L Forsling

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

Sep 1, 1981·British Journal of Haematology·R LombardiR Coppola

Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation

Apr 1, 1981·British Journal of Haematology·S S JohnsonW E Hathaway

A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma

Feb 1, 1981·British Journal of Haematology·D S McLellanA Aronstam

Evaluation of some coagulation parameters in cerebral ischemia

Apr 1, 1983·Acta Neurologica Scandinavica·R MarraB Bizzi

New methods in coagulation

Jan 1, 1981·Critical Reviews in Clinical Laboratory Sciences·D A Triplett

Mediators produced by the endothelial cell

Dec 1, 1988·Hypertension·R J GryglewskiJ R Vane

Gabexate mesilate and antithrombin III for intraoperative anticoagulation in heparin pretreated patients

Sep 28, 1999·Perfusion·M RanucciS Brozzi

Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia

Apr 1, 1985·Scandinavian Journal of Haematology·G BrattD Lockner

Comparisons of one-stage and two-stage assays of Factor VIII:C

Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·T W Barrowcliffe

A statistical analysis of factors predisposing patients to heparin resistance

Apr 18, 2006·Perfusion·Tanee ChanChong Hee Lim

Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass.

Jul 14, 2020·General Thoracic and Cardiovascular Surgery·Satoshi MatsushitaAtsushi Amano

Risk associations and predictive tests

Oct 1, 1978·Scottish Medical Journal·G P McNicol, J A Davies

Factor VIII:C relationships to selected lipids, age, and gender in healthy adults

Aug 1, 1990·The American Journal of the Medical Sciences·M J CorsautR M Kasa

Markers of increased thrombin generation

Oct 1, 1990·La Ricerca in Clinica E in Laboratorio·D Prisco

❮ Previous

Next ❯

Related Concepts

Related Feeds

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting

Abstract

References

New rapid method for diagnosis of deep venous thrombosis

The appearance of schistocytes in the peripheral blood in correlation to the degree of disseminated intravascular coagulation. An experimental study in rats

Factor VIII and factor-VIII-related antigen in multiple myelomatosis and related conditions

A radioimmunoassay for platelet factor 4

Generation of a thrombin-like activity in late pregnancy

Diagnosis of von Willebrand's disease by means of the quantitative immunological assay of factor VIII-related antigen (author's transl)

The detection of factor-VIII-like antigen in haemophilic carriers and in patients with raised levels of biologically active factor VIII

Measurement of fibrinopeptide A in human blood

Activated coagulation factors: in-vivo and in-vitro studies

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

The defibrination syndrome: clinical features and laboratory diagnosis

Citations

Increased factor VIII/vWf levels in patients with reduced platelet number

Coagulation parameters and heparin levels in open-heart surgery

Relationships between metabolic and hemostatic variables in uncomplicated diabetes

Hypoglycemic therapy and hemostasis in maturity- onset diabetes mellitus: existence of an early prethrombotic state

Factor VIII-related antigen levels in normal pregnancy and puerperium

Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina

Coagulation activation and hyperviscosity in infection

Serial changes in coagulation and viscosity during sickle-cell crisis

Factor VIII complex in uraemia and effects of haemodialysis

Haemostatic function in myocardial infarction

Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients

Coagulation problems in human pregnancy

Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping

Activation of intrinsic coagulation pathway in pre-eclampsia

Aluminium hydroxide adsorption and factor VIII clotting assays

Factor VIII related antigen and coagulant activity in intrauterine growth retardation

The influence of LMW heparin on the coagulation and fibrinolytic response to surgery

The use of a macroscopic aggregation test for Von Willebrand factor as an indicator of endothelial damage

A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin

Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma

Factor VIII related antigen in gestational trophoblastic disease

Platelet function and coagulation in normal and preeclamptic pregnancy

Immunoquantitation of von Willebrand factor (factor VIII-related antigen) in vinyl chloride exposed workers.

Nutritional prevention of pre-eclampsia--a special role for 1 series prostaglandin precursors?

Immunoquantitation of factor VIII-related antigen (von Willebrand factor antigen) in prostate cancer.

The destruction of factor VIII clotting activity by thrombin and plasmin

Plasma levels of protease inhibitors in acute myeloid leukemia at the onset of the disease and during antiblastic therapy

The factor VIII ratio in normal and pathological pregnancies

Predictors for heparin resistance in patients undergoing coronary artery bypass grafting

Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis

Plasma haemostatic factors and diabetic retinopathy

Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation

A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma

Evaluation of some coagulation parameters in cerebral ischemia

New methods in coagulation

Mediators produced by the endothelial cell

Gabexate mesilate and antithrombin III for intraoperative anticoagulation in heparin pretreated patients

Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia

Comparisons of one-stage and two-stage assays of Factor VIII:C

A statistical analysis of factors predisposing patients to heparin resistance

Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass.

Risk associations and predictive tests

Factor VIII:C relationships to selected lipids, age, and gender in healthy adults

Markers of increased thrombin generation

Related Concepts

Related Feeds

Blood Clotting Disorders

Related Papers

Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy

The destruction of factor VIII clotting activity by thrombin and plasmin

Asbestosis

Studies on the haemostatic system in peripheral arterial disease. 2. Variations in factor VIII components (FVIII:C ; FVIIIR:Ag ; FVIII:WF) before and after venous occlusion

Basic considerations on treatment of increased platelet aggregation in diabetic vasculopathic patients